Dr. Andrew H. Marple, MD, PhD

Dr. Marple practices at Intercoastal Medical Group Inc in Sarasota, Florida.

Dr. Marple's NPI, 1083093769, was assigned on May 27, 2015. Dr. Marple graduated from Rutgers New Jersey Medical School in 2015. Dr. Marple holds Florida license ME150864.

Dr. Marple's primary practice is Intercoastal Medical Group Inc, at 943 S Beneva Rd, Sarasota, FL 34232 in Sarasota County. The practice phone is (941) 955-1108.

Dr. Marple's primary practice is Intercoastal Medical Group Inc in Sarasota, Florida. Dr. Marple is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Intercoastal Medical Group. Dmand AI also links Dr. Marple to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marple practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Marple's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Marple is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Marple's licenses on file in 3 states: Florida, Maryland and Connecticut.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Marple treats.

CMS data shows 348,551 Medicare services from Dr. Marple across 66 procedure codes in 2024, for 1,074 Medicare patients. Medicare paid $2,607,572 for them.

CMS counts 1,074 Medicare patients who saw Dr. Marple in 2024. The largest group is 75 to 84, with 478 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marple's median patient age at 76, with 57% women.

In 2024, Dr. Marple wrote 1,478 Medicare Part D claims for 338 patients. 80% of them were for generic drugs. CMS names the drug for 1,200 of them, across 28 drugs with 11 or more claims each, at $1,323,824 in total drug cost. In 2023, CMS named 1,034 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Marple for performance year 2024, reported individually. Dr. Marple accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marple as offering telehealth.

Dmand AI links 10 papers to Dr. Marple, published from 2010 to 2021. The most frequent topics are Immunotherapy, Adoptive, Receptors, Chimeric Antigen and Cell Line, Tumor. Dr. Marple's most frequent co-authors are Challice L. Bonifant, MD, PhD, Ruyan Rahnama, MD and Mili Arora, MD.

CMS Open Payments shows 138 general payments to Dr. Marple from 42 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 99% of the total. Celgene Corporation paid the most, $458.

Dr. Marple graduated from Rutgers New Jersey Medical School in 2015.

Dr. Marple is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.